Preliminary outcome of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin’s lymphoma: single institution experience

By Wang Bufei   Huang Huiqiang   Bu Qing   Xia Zhongjun   Lin Xubin   Wang Fenghua   Li Yuhong   Peng Yulong   Pan Zhanhe   Wang Shusen   Lin Tongyu   Jiang Wenqi   Guan Zhongzhen  

The Chinese-German Journal of Clinical Oncology, Vol. 5, Iss. 6, 2006-12 ,pp. : 402-406

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) Versus DHAP (Cytosine Arabinoside-Cisplatin-Dexamethasone) as Salvage Chemotherapy in Patients with Relapsed or Refractory Lymphoma

By Abalı Huseyin   Urun Yuksel   Oksuzoğlu Berna   Budakoğlu Burcin   Yıldırım Nuriye   Guler Tunc   Ozet Gulsum   Zengin Nurullah  

Cancer Investigation, Vol. 26, Iss. 4, 2008-05 ,pp. : 401-406

Informa Healthcare

Access to resources Recommend Favorite

Long-term response of gemcitabine plus docetaxel chemotherapy regimen for extraskeletal osteosarcoma: A case report

By            

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2567-2571

Spandidos Publications

Access to resources Recommend Favorite

Paclitaxel-based chemotherapy for patients with refractory or relapsed nonseminomatous germ cell tumors

By Amato R.J.   Prow D.M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 5, Iss. 4, 2000-07 ,pp. : 134-138

Elsevier

Access to resources Recommend Favorite

Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience

By Silvani A.   Salmaggi A.   Eoli M.   Lamperti E.   Broggi G.   Marras C.   Fariselli L.   Milanesi I.   Fiumani A.   Gaviani P.   Erbetta A.   Giovagnoli A.   Pollo B.   Botturi A.   Boiardi A.  

Journal of Neuro-Oncology, Vol. 82, Iss. 3, 2007-05 ,pp. : 273-279

Springer Publishing Company

Access to resources Recommend Favorite